Simulations Plus Other Share Holders Equity 2010-2025 | SLP
Simulations Plus other share holders equity from 2010 to 2025. Other share holders equity can be defined as field containing the sum of all current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
Simulations Plus Annual Other Share Holders Equity
(Millions of US $) |
| 2024 |
$0 |
| 2023 |
$0 |
| 2022 |
$0 |
| 2021 |
$0 |
| 2020 |
$0 |
| 2019 |
$0 |
| 2018 |
$0 |
| 2017 |
$0 |
| 2016 |
$0 |
| 2015 |
$0 |
| 2014 |
$0 |
| 2013 |
$0 |
| 2012 |
$0 |
| 2011 |
$0 |
| 2010 |
$0 |
| 2009 |
$0 |
Simulations Plus Quarterly Other Share Holders Equity
(Millions of US $) |
| 2025-02-28 |
|
| 2024-11-30 |
|
| 2024-08-31 |
|
| 2024-05-31 |
|
| 2024-02-29 |
|
| 2023-11-30 |
|
| 2023-08-31 |
|
| 2023-05-31 |
|
| 2023-02-28 |
|
| 2022-11-30 |
|
| 2022-08-31 |
|
| 2022-05-31 |
|
| 2022-02-28 |
|
| 2021-11-30 |
|
| 2021-08-31 |
|
| 2021-05-31 |
|
| 2021-02-28 |
|
| 2020-11-30 |
|
| 2020-08-31 |
|
| 2020-05-31 |
|
| 2020-02-29 |
|
| 2019-11-30 |
|
| 2019-08-31 |
|
| 2019-05-31 |
|
| 2019-02-28 |
|
| 2018-11-30 |
|
| 2018-08-31 |
|
| 2018-05-31 |
|
| 2018-02-28 |
|
| 2017-11-30 |
|
| 2017-08-31 |
|
| 2017-05-31 |
|
| 2017-02-28 |
|
| 2016-11-30 |
|
| 2016-08-31 |
|
| 2016-05-31 |
|
| 2016-02-29 |
|
| 2015-11-30 |
|
| 2015-08-31 |
|
| 2015-05-31 |
|
| 2015-02-28 |
|
| 2014-11-30 |
|
| 2014-08-31 |
|
| 2014-05-31 |
|
| 2014-02-28 |
|
| 2013-11-30 |
|
| 2013-08-31 |
|
| 2013-05-31 |
|
| 2013-02-28 |
|
| 2012-11-30 |
|
| 2012-08-31 |
|
| 2012-05-31 |
|
| 2012-02-29 |
|
| 2011-11-30 |
|
| 2011-08-31 |
|
| 2011-05-31 |
$0 |
| 2011-02-28 |
$0 |
| 2010-11-30 |
$0 |
| 2010-08-31 |
$0 |
| 2010-05-31 |
$0 |
| 2010-02-28 |
$0 |
| 2009-11-30 |
$0 |
| 2009-08-31 |
$0 |
| 2009-05-31 |
$0 |
| 2009-02-28 |
$0 |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Computer Software |
$0.351B |
$0.070B |
|
Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. They have two other businesses, Words+, Inc. and FutureLab, which are based on its proprietary software technologies.
|
